[ad_1]
Synopsis
After Reliance, Tata and Amazon, Walmart-backed Flipkart has marked its attendance to get a pie of India’s growing e-pharmacy market. The online retail giant’s Sastasundar Marketplace investment has made it a five-way fight as one can’t ignore Pharmeasy’s aggressive moves. The question now is how the deal stands in front of the competition.
On November 19, 2021, a little-known company, operating modestly at the peripheries of India’s up and coming online-pharmacy market, stole the thunder from Pharmeasy’s much-anticipated entry into public markets. Sastasundar Marketplace, a step-down subsidiary of a listed firm, Sastasundar Ventures, suddenly captured the attention of business news portals and investors, as Walmart-backed Indian e-commerce giant Flipkart announced its acquisition
BY
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Get Offer
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise
[ad_2]
Source link
